# FDA recall D-0184-2023

> **Pfizer Inc.** · Class I · drug recall initiated 2022-12-22.

## Product

Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial,  10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045.  NDC Vial 0409-3515-11; NDC Carton 0409-3515-01

## Reason for recall

Presence of Particulate Matter: Glass particulate matter detected in injectable.

## Distribution

USA nationwide and Puerto Rico

## Key facts

- **Recall number:** D-0184-2023
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-22
- **Report date:** 2023-02-01
- **Termination date:** 2024-08-07

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0184-2023

## Citation

> AI Analytics. FDA recall D-0184-2023. Retrieved 2026-07-15 from https://api.ai-analytics.org/recall/D-0184-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*